Prostate-specific antigen (PSA) has become an indispensable tumor marker for the diagnosis of prostate cancer and has been widely used for disease monitoring, staging and diagnosis, and early diagnosis, in addition to being an immunohistochemical marker (9). The gene discussed is KLK3; the disease is prostate carcinoma.